What Medaffcon does

Medaffcon is a Nordic pharmaceutical and healthcare consulting firm headquartered in Espoo, Finland, with a regional office in Stockholm, Sweden (Medaffcon AB). The company is a wholly-owned subsidiary of Tamro, a Finnish pharmaceutical wholesale and healthcare logistics provider, and operates with shared executive leadership with the parent. Founded around 2009-2010, Medaffcon delivers four integrated practice lines: Real World Evidence (RWE) generation across the product lifecycle, Market Access strategy and reimbursement support across Nordic markets, Medical Affairs services including medical communication and advisory boards, and Expert Resourcing placing senior consultants into client organisations.

The company's technology stack applies modern data solutions to health economic and clinical work, including OMOP Common Data Model-based data harmonisation, synthetic data and digital twins for drug development support, and machine learning and AI-based solutions for analytics. Service delivery is powered by a small bench of highly credentialed staff (PhDs, MScs) supported by an external expert network spanning pharma, healthcare, academia, and the OHDSI research community.

Medaffcon's commercial model is professional services: project-based, quote-based engagements priced against client needs, reached via direct expert-to-expert sales through business development managers. Pricing is not publicly disclosed. The primary customer segments are pharmaceutical companies requiring evidence generation, market entry strategy, and reimbursement support, with healthcare organisations and academic/research institutions as adjacent segments. Geographic focus is explicitly Nordic (Finland and Sweden), with no claimed global footprint.

Name

Medaffcon

Legal name

Medaffcon Oy

Website

https://medaffcon.fi

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Medaffcon is a Nordic pharmaceutical and healthcare consulting firm providing Real World Evidence, Market Access, Medical Affairs, and Expert Resourcing services to pharmaceutical companies across Finland and Sweden, operating as a subsidiary of Tamro.

Ownership category

akta.pro rank

Product category

Pharmaceutical Consulting

NAICS

Scientific Research and Development Services (5417), Management Consulting Services (54161), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)

akta.pro primary industry

Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN)

akta.pro secondary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

Keywords

• Real world evidence
• Market access consulting
• Medical affairs services
• Health economics research
• Pharmaceutical consulting

Headquarters

HQ city

Espoo

HQ country

Finland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Professional Consulting Services: Medaffcon generates revenue through providing expert consulting services in Real World Evidence, Market Access, and Medical Affairs. Services are delivered by highly qualified experts (PhDs, MSc holders) and include project-based consulting, study execution, and strategic advisory engagements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Medaffcon provides tailored research and expert consulting services to the pharmaceutical industry and healthcare sector across the Nordics. The company delivers four interconnected service lines — Real World Evidence (RWE) generation, Market Access strategy and modeling, Medical Affairs support, and Expert Resourcing — that span the pharmaceutical product lifecycle from evidence generation and market entry to medical communications and interim expert staffing.

Product overview

Medaffcon is a Nordic consulting and research organization offering a portfolio of four interconnected expert services: Real World Evidence (RWE), Market Access, Medical Affairs, and Expert Resourcing. These services are designed to work together across the pharmaceutical product lifecycle — from evidence generation and market entry strategy to medical communications and expert staffing — supporting pharmaceutical and healthcare actors in the Nordic markets. The company combines medical and health economic perspectives with data solutions, leveraging a cooperative network spanning the pharmaceutical industry, healthcare, academia, and the research community.

Differentiator

Problem solved

Functional benefit

Products and services

• Real World Evidence (RWE) Tailored evidence generation across the pharmaceutical product lifecycle — from gap analysis and strategy workshops to full study execution, fast-track data requests, interactive tools, and payer-ready evidence packages. Targeted at pharmaceutical and healthcare organizations needing RWE studies to support knowledge-based decision making.
• Market Access Support for all phases of market entry and life-cycle management — from strategy and modeling to reimbursement submissions, risk sharing, interactive decision tools, and market analytics across Nordic markets. Targeted at pharmaceutical companies commercializing or managing products across the Nordics.
• Medical Affairs Flexible support in medical communication, literature synthesis, advisory boards, stakeholder mapping, medical training, healthcare environment assessments, and expert interim staffing to strengthen clients' medical strategy. Targeted at pharmaceutical companies and healthcare organizations with medical affairs functions.
• Expert Resourcing Provides client access to a network of healthcare, pharmaceutical, and research experts for consulting assignments and interim staffing needs. Targeted at pharmaceutical and healthcare organizations needing specialized expert support on a flexible basis.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• TamrocoreStrategic or Co-development PartnerTamro is a pharmaceutical wholesale and healthcare logistics company that serves as Medaffcon's parent company. Heikki Koski, CEO of Medaffcon Group, continues to serve as a member of Tamro's executive team. He previously served as Director of Service Business and Development at Tamro and was a board member of Medaffcon since 2020. Medaffcon operates as a subsidiary of Tamro with shared executive leadership.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• PharmaLex: Regulatory, market access, and pharmacovigilance consulting firm to pharma. Comparable to Medaffcon on Market Access and reimbursement submissions across European markets.
• TFS HealthScience: European mid-sized CRO with Nordic presence and full clinical/market access services. Comparable to Medaffcon on pharma services and Nordic coverage.
• Evidera (PPD / Thermo Fisher): Specialist HEOR, RWE, and market access consulting firm, now part of PPD/Thermo Fisher. Direct peer to Medaffcon's HEOR/RWE/Market Access core, with similar service portfolio.
• Medfiles: Finnish CRO offering clinical and regulatory services to pharma. Direct Nordic peer to Medaffcon, with overlapping pharma services and Finnish footprint.
• Cytel: Statistical and data-analytics focused CRO with strong RWE and biostatistics offerings. Comparable to Medaffcon on data-driven RWE study execution.

Broad incumbents

• IQVIA: Global leader in clinical, real-world evidence, HEOR, and market access services to pharma. Medaffcon competes on the same RWE/Market Access deliverables but with a Nordic specialization versus IQVIA's global scale.
• Syneos Health: Global biopharmaceutical solutions organization including clinical, commercial, and RWE services. Overlaps with Medaffcon on RWE and commercial/market access.
• ICON plc: Global CRO and healthcare intelligence firm with RWE, HEOR, and market access capabilities. Comparable to Medaffcon on RWE and Market Access offerings but vastly larger scale and geographic reach.
• Parexel International: Global CRO with commercial launch, market access, and real-world evidence services. Overlaps with Medaffcon on Market Access and RWE work for pharma clients.

Emerging players

• Lattice Group: Specialist HEOR and market access consulting firm focused on payer evidence generation. Comparable to Medaffcon on HEOR-focused services and payer evidence work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UC5IF5_fKnjVHecNuCWnRkKg
• LinkedInlinkedin.com/company/medaffcon-oy
• Xx.com/medaffcon

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medaffcon